Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06951880
PHASE1

A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers

Sponsor: AstraZeneca

View on ClinicalTrials.gov

Summary

The main purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) of AZD4916 in healthy adult participants.

Official title: A Phase I, Randomized, Single-blind, Placebo-controlled, 2-Part Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD4916 Following Single- and Multiple-ascending-dose Administration to Healthy Adult Volunteers (Including Japanese and Chinese Healthy Volunteers)

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

160

Start Date

2026-07-23

Completion Date

2027-10-25

Last Updated

2026-06-15

Healthy Volunteers

Yes

Interventions

DRUG

AZD4916

AZD4916 will be administered as oral solution.

OTHER

Placebo

Placebo will be administered as oral solution.

Locations (2)

Research Site

Glendale, California, United States

Research Site

Harrow, United Kingdom